Valsalva Maneuver & Modified Valsalva in SVT: A Complete Clinical Guide
Supraventricular tachycardia (SVT) is a common narrow-complex tachyarrhythmia caused by a re-entry circuit above the ventricles. The first-line therapy in hemodynamically stable patients is vagal maneuvers, with the Valsalva maneuver (VM) being the most widely used. In recent years, the Modified Valsalva Maneuver (MVM) has gained prominence due to significantly improved success rates.
---
1. Why Vagal Maneuvers Work
The AV node is sensitive to parasympathetic stimulation. Increasing vagal tone temporarily slows AV nodal conduction, interrupting AV-dependent re-entry circuits such as:
AVNRT
AVRT (orthodromic WPW)
Atrial tachycardia with AV-dependent conduction (rarely)
Vagal techniques manipulate intrathoracic pressure or baroreceptor reflexes to activate the vagus nerve.
---
2. Traditional Valsalva Maneuver
Mechanism
The maneuver increases intrathoracic pressure and stimulates baroreceptors, triggering reflex vagal discharge. The AV node slows → the re-entry circuit breaks → sinus rhythm restores.
How to Perform (Standard Method)
Patient blows into a syringe or manometer to generate 40 mmHg pressure for 15 seconds.
The patient remains seated or semi-reclined.
Why It Often Fails
Pressure is not standardized.
Lack of the rapid preload/afterload shift needed to generate a strong vagal reflex.
Success rate usually 10–20% in real-world practice.
---
3. Modified Valsalva Maneuver
Developed after the REVERT Trial, this approach significantly improves conversion rates.
Steps (REVERT Protocol)
Phase 1 — Strain:
Patient performs the classic Valsalva:
Blow into a 10 mL syringe to move the plunger
Maintain 40 mmHg pressure for 15 seconds
Phase 2 — Postural Change:
Immediately after the strain:
Quickly lay the patient flat
Raise legs to 45° for 15 seconds
Phase 3 — Recovery:
Return the patient to a semi-reclined position and check rhythm
Mechanism Behind Higher Success
The abrupt transition from high intrathoracic pressure to sudden venous return enhances vagal tone.
Increased preload stimulates baroreceptors strongly.
The combination produces a more potent and sustained vagal response.
Success Rate
Standard VM: ~17%
Modified VM: ~43% (REVERT Trial)
This makes the modified VM the most effective non-pharmacological SVT treatment.
---
4. Practical Tips for Clinicians
Ensure Proper Pressure
Use a manometer or syringe technique to reliably generate 40 mmHg.
Avoid Hyperventilation
Patients often hyperventilate due to anxiety; reassure them.
Use in Right Patients
Stable
Narrow-complex tachycardia
No hypotension, ischemia, or pulmonary edema
Contraindications
Recent MI
Severe aortic stenosis
Glaucoma
Retinopathy
Known aneurysms
Hemodynamic compromise
---
5. When to Avoid and Move to Medications
If two attempts of Modified VM fail:
Give Adenosine (6 mg → 12 mg → 12 mg)
Or use alternatives like verapamil/diltiazem if adenosine is contraindicated
---
6. Special Notes
Modified VM is safe for most adults; can be done in ED, ward, or prehospital settings.
Always reassess rhythm immediately after the maneuver.
Document baseline rhythm, attempt duration, and post-maneuver ECG.
---
Conclusion
The Valsalva maneuver remains the cornerstone initial treatment for SVT, but the Modified Valsalva Maneuver has transformed outcomes by more than doubling the likelihood of success. Easy to perform, rapid, and non-invasive, it should be the default first-line technique for stable SVT in modern clinical practice.
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you